1.3 Controlled Drugs, Pharmacovigilance & Error Prevention

1.3 Controlled Drugs, Pharmacovigilance & Error Prevention

The management of controlled drugs and the prevention of medication errors represent fundamental aspects of clinical safety and legal compliance in New Zealand healthcare settings. Registered Nurses must strictly comply with national drug control legislation, uphold rigorous clinical governance when handling controlled substances, and actively participate in pharmacovigilance and quality improvement frameworks.

---

Misuse of Drugs Act 1975 & Drug Classifications

In Aotearoa New Zealand, controlled drugs are governed by the Misuse of Drugs Act 1975 and the Misuse of Drugs Regulations 1977. Medicines classified under this legislation are categorized based on their risk of harm and potential for misuse or addiction:

---

Controlled Drug Register Governance & Storage Standards

1. Physical Storage Requirements:

• Controlled Drugs (Class A and B) must be stored in a metal, double-locked Controlled Drugs Cabinet or safe that is permanently affixed to the building structure.
• Access keys must be carried physically by a designated Registered Nurse (Shift Keyholder) and never left unattended.

2. Register Documentation Rules:

• The Controlled Drug Register (CD Register) is a legally binding document. It must be a bound book with pre-numbered pages (or an accredited electronic CD system with immutable audit logs).
• A separate dedicated page must be maintained for each individual drug formulation, strength, and brand.
• Immediate Entry: Transactions must be recorded immediately at the time of preparation/administration.
• Signatures: Every administration entry requires the legible signatures or electronic sign-offs of two qualified clinicians (normally two RNs, or one RN and one Prescriber).
• No Erasures: Mistakes must not be erased, blacked out, or altered with correction fluid. Errors must be corrected with a single line through the entry, initialed, dated, and explained by both checking nurses.

---

Stock Reconciliation, Transfer & Wasting Protocols

1. Shift Stock Counts:

At every nursing shift handover, two Registered Nurses (one from the outgoing shift, one from the incoming shift) must physically count every controlled drug container in the safe and reconcile the physical count against the running balance in the CD Register.

2. Wasting and Disposal Protocols:

When a partial dose of a controlled drug is administered (e.g., 5 mg given from a 10 mg/mL morphine ampoule):

• The remaining 5 mg unused portion must be rendered unusable and destroyed immediately at the medication bench (e.g., squirted into a specialized drug denaturing gel kit or sharps bin).
• The destruction must be physically witnessed by the second checking RN.
• Both nurses must sign the CD Register recording the prescribed dose given, the amount wasted, and the remaining stock balance.

---

Medication Incident Management, Just Culture & Open Disclosure

When a medication error or near miss occurs, clinical priority must focus on patient safety, followed by transparent reporting and systemic analysis.

Medication Incident Occurs -> Assess & Stabilize Patient -> Notify Prescriber & Charge Nurse -> Open Disclosure with Patient/Whānau -> Log Incident (e.g., Datix) -> Root Cause Analysis (RCA)

1. Just Culture Model:

New Zealand healthcare promotes a Just Culture framework (pioneered by James Reason), which distinguishes between three types of clinical behaviors:

• Human Error (Unintentional slip or mistake): Support the clinician; examine system safeguards.
• At-Risk Behavior (Taking shortcuts, drift from protocol): Coach the clinician; remove system incentives for shortcuts.
• Reckless Conduct (Conscious disregard of substantial safety risk): Remedial or disciplinary action.

2. Open Disclosure (HDC Code of Rights):

Under Rights 5 and 6 of the Code of Health and Disability Services Consumers' Rights, patients have the right to honest, transparent communication. If a medication error occurs, the clinical team must provide a timely explanation of what happened, potential impacts, remedial steps taken, and measures implemented to prevent recurrence.

---

Pharmacovigilance & Adverse Drug Reaction (ADR) Reporting to CARM

Pharmacovigilance involves the ongoing monitoring of medicine safety, efficacy, and adverse reactions following registration.

Centre for Adverse Reactions Monitoring (CARM):

• Located at the University of Otago in Dunedin, CARM is New Zealand's national repository for adverse drug reaction data.
• What to Report: Unexpected ADRs, serious reactions (hospitalization, life-threatening events), reactions to newly approved medicines, and vaccine adverse events.
• Reporting Mechanism: RNs submit ADR reports directly via the online CARM portal or integrated electronic health record (EHR) yellow card reporting modules.
• Medsafe Action: CARM data is analyzed by the Medicines Adverse Reactions Committee (MARC), which may issue national safety alerts, update product datasheets, or restrict drug indications.